Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biocept Inc BIOCQ

Healthcare Biotechnology
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular... see more

Recent & Breaking News (GREY:BIOCQ)

Biocept Is An Emerging Leader In Liquid Biopsy; Roth Starts At Buy

Benzinga.com  June 6, 2016

Biocept Launches Liquid Biopsy Immuno-Oncology PD-L1 Test

PR Newswire May 31, 2016

High Sensitivity of Biocept's Target Selector Blood-Based Liquid Biopsy Tests Featured in Two Abstracts at ASCO

PR Newswire May 25, 2016

Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests

PR Newswire May 23, 2016

Biocept Launches Proprietary Liquid Biopsy Test to Detect RET Fusions in Patients with Lung Cancer

PR Newswire May 19, 2016

Biocept Reports 2016 First Quarter Financial Results

PR Newswire May 12, 2016

Biocept Expands Intellectual Property Portfolio with 12th Granted Patent on its Key Liquid Biopsy Technology

PR Newswire May 12, 2016

Biocept to Hold 2016 First Quarter Conference Call on May 12

PR Newswire May 5, 2016

Biocept to Present at the Inaugural Joseph Gunnar PIONEERS 2016 Conference

PR Newswire May 2, 2016

Biocept, Inc. Announces Pricing Of $5 Million Public Offering Of Common Stock And Warrants

PR Newswire April 29, 2016

Biocept Inc. Announces Proposed Public Offering Of Common Stock And Warrants

PR Newswire April 28, 2016

Biocept Collaborates with MedStar Georgetown University Hospital for Liquid Biopsy Study

PR Newswire April 27, 2016

Biocept Continues International Expansion through Agreement with Quest Diagnostics Mexico

PR Newswire April 18, 2016

Biocept to Present at the 15th Annual Needham Healthcare Conference

PR Newswire April 6, 2016

Biocept Forms Clinical Advisory Board of World-Renowned Oncologists

PR Newswire March 30, 2016

Biocept's Mark Foletta Honored with CFO Lifetime Achievement Award

PR Newswire March 23, 2016

Biocept to Collaborate on Biopharma Company Clinical Trial by Identifying Biomarkers Found in Cerebral Spinal Fluid for Patients with Lung Cancer that has Spread to the Brain

PR Newswire March 21, 2016

Biocept Reports 2015 Fourth Quarter and Full Year Financial Results

PR Newswire March 9, 2016

Biocept Secures Agreement with FedMed

PR Newswire March 9, 2016

Biocept to Present at the 28th Annual ROTH Conference

PR Newswire March 7, 2016